Navigation Links
Percutaneous aortic valve replacement- a revolution in Cardiac Surgery

The aortic valve in the heart is the valve that governs the flow of blood into a large blood vessel namely the aorta, which supplies blood to various organs of the body. // It prevents the blood from flowing back inside the heart from the rest of the body.

The effective functioning of the heart depends on the proper functioning of the aortic valve. The aortic valve can be defective in some cases, leading to a compromise in the same. The defect can be present right form birth or it can be acquired as a result of other diseases.

This cardiac defect can be corrected by a surgical technique called aortic valve replacement that greatly increases the life expectancy of the patients. Nearly 200,000 patients undergo surgical valve replacement worldwide every year. However not all patients can undergo the surgery.

Approximately 2/3 rd of the patients do not receive the surgery due to associated risk factors and morbidity or patient refusal due to fear of lifestyle changes following surgery in elderly patients. The number is only expected to rise, considering the density of aging population.

Thanks to the promise offered by a new, less invasive, therapeutic surgical technique called percutaneous aortic valve replacement that is becoming a reality. The surgical procedure has given hope for a number of patients who cannot currently be treated with traditional surgical techniques.

The surgery has been performed successfully in a cardiac care centre in Canada either under local anaesthesia or under light sedation. Reports regarding the valve performance have been excellent and there has not been a single case of valve failure when the valve was successfully placed (80% of the cases). High mortality during follow-up has been related to non-valvular causes, mainly the evolution of life-threatening comorbidities.

Two multicentre studies have just begun enrollment in Europe (REVIVE trial) and the US (REVIVAL trial
'"/>




Page: 1 2

Related medicine news :

1. Mutations in NOTCH1 cause an early developmental defect in the aortic valve
2. Award for TTK Chitra heart valve prosthesis
3. Defective heart valve causes problems
4. Mutations in NOTCH1 cause an early developmental defect in the aortic valve
5. Heart valve surgery may be replaced by new heart therapy
6. Laboratory Heart valve to study Heart diseases
7. Hemopurifier may revolutionise AIDS treatment
8. Best out of waste: Microbiological revolution!
9. Cardiac diseases develop early
10. Heart problems detected better with a Cardiac MRI
11. Cardiac events better treated with intense cholesterol-lowering regime
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: aortic valve replacement revolution Cardiac Surgery

(Date:7/12/2014)... HealthDay Reporter SATURDAY, July ... that a surgical technique used to grind up uterine growths ... of spreading cancer to other parts of a woman,s body, ... the Food and Drug Administration also said that women who ... should sign a written consent stating that they understand the ...
(Date:7/12/2014)... The fastest-growing mobile technology is LTE ... of LTE networks continues to grow due to the ... have increased mobile data traffic, which is a major ... Communications Test and Measurement equipment comply with industry standards, ... Test and Measurement Market is estimated to grown from ...
(Date:7/12/2014)... PA (PRWEB) July 12, 2014 "The second ... it’s uncomfortable and painful to wear shoes," said an inventor ... special sock that prevents this from happening. , He then ... effective way to prevent the second and big toes from ... endurance while wearing shoes. Ergonomic and easy to use, it's ...
(Date:7/12/2014)... With prom shopping reaching its final days, ... ready to showcase its new and trendy apparels. Recently, ... dresses in its online shop. Additionally, it is now ... elegant gowns. According to the company’s sales manager, the ... 2014. , He says, “Now, worldwide clients can ...
(Date:7/12/2014)... York, NY (PRWEB) July 12, 2014 As ... (the National Institute of Standards and Technology), the June 25th, ... the electronic discovery world. It was also ... finally in, depending on whether it was seen from an ... But this much is fact, there is now precedent which ...
Breaking Medicine News(10 mins):Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 2Health News:FDA Advisers Weigh Risks of Procedure for Removal of Uterine Fibroids 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 4Health News:North America Communication Test and Measurement (CT&M) Market Worth $1.9 Billion by 2018 - New Report by MicroMarket Monitor 5Health News:VogueQueen.com Updates Its Summer Collection With New And Trendy Evening Dresses 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5
... is deeply disturbed that the Food and Drug ... vulnerable populations such as women of child-bearing age, ... recommendation flies in the face of decades of ... of mercury from food, especially on the developing ...
... Univita Health will provide an integrated approach to home-based care and ... 15 The launch of a new company aimed at promoting ... Univita Health is introducing new programs and innovating existing services to ... , "Due to falling birthrates and increased ...
... per cent of the men who took part in the ... trial were diagnosed with the disease and the majority of ... published in the December issue of the urology journal ... women aged from 55 to 74 took part in the ...
... Dec. 15 Today, a parent of a mercury-poisoning victim joined ... proposal to stop warning pregnant women and children about exposure risks ... "We,ve known for years that mercury is toxic to ... individual,s status. For FDA to suddenly change the equation to ...
... hair loss for,both men and women is a very traumatic ... help our clients that worked unlike many potions,lotions and product ... it is the only true hair regeneration laser on the ... Medical, Northwestern,University , Mass General, etc.). They are ...
... 15 Greenway Medical Technologies,Inc. today announced that ... (EHR) solution, PrimeSuite(R), won,three "Best in KLAS" awards ... KLAS Awards,report. For the third consecutive year, ... ambulatory EMR category for practices having between six ...
Cached Medicine News:Health News:CU Statement on FDA Position on Mercury From Fish Consumption 2Health News:Launch of New 'Independent Aging' Company Will Address the Needs of the Growing Senior Population 2Health News:Launch of New 'Independent Aging' Company Will Address the Needs of the Growing Senior Population 3Health News:USA's largest ever prostate cancer screening program shows high compliance and consistent results 2Health News:USA's largest ever prostate cancer screening program shows high compliance and consistent results 3Health News:FDA's Proposed Mercury Fish Advice Based on Flawed Science, Say MD and Anti-Mercury Advocates 2Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Wins Three 'Best in KLAS' Awards 2Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Wins Three 'Best in KLAS' Awards 3Health News:Greenway Medical Technologies' EHR Solution, PrimeSuite, Wins Three 'Best in KLAS' Awards 4
(Date:7/10/2014)... 11. Juli 2014  Dilon Technologies, ... die molekulare Bildgebung, einschließlich molekularer Bildgebung ... CE-Zulassung für sein Navigator ® -Gamma-Sondensystem ... das Produkt jetzt europaweit vertreiben. Dilon ... der europäischen Länder ausgedehnt und bereits ...
(Date:7/10/2014)... SAN DIEGO , July 10, 2014  RESMED INC. ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
(Date:7/10/2014)... , July 10, 2014   Ventana Medical Systems, ... announced it has entered into an agreement with Merck ... as EMD Serono in the United States ... collaborate with Merck KGaA,s biopharmaceutical division on the development ... undisclosed target using Ventana,s proprietary diagnostic assays. In alignment ...
Breaking Medicine Technology:Dilon erhält CE-Zulassung für sein Navigator-Gamma-Sondensystem 2ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... Pro Osteon Bone Graft Substitutes a natural ... from cadaver bone, but such grafts may ... disease transmission. Interpore Cross has developed the ... to address these needs, offering surgeons a ...
... Healos is an osteoconductive matrix constructed ... fully coated with hydroxyapatite through a ... with autogenous bone marrow aspirate, Healos ... cell attachment, proliferation and differentiation. The ...
Weitlaner-Locktite retractors, blunt, 11 cm total length....
Sharp Weitlaner Retractor....
Medicine Products: